Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascale V Guillot

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Frontiers in Pharmacology|March 19, 2015
Corrigendum: In utero therapy for congenital disorders using amniotic fluid stem cellsDurrgah L Ramachandra, Sheng-Wen Steven Shaw, Panicos Shangaris, et al.
Frontiers in Pharmacology|January 8, 2015
In utero therapy for congenital disorders using amniotic fluid stem cellsDurrgah L Ramachandra, Steven S W Shaw, Panicos Shangaris, et al.
Stem Cells (Dayton, Ohio)|December 23, 2006
Widespread distribution and muscle differentiation of human fetal mesenchymal stem cells after intrauterine transplantation in dystrophic mdx mouseJerry Chan, Simon N Waddington, Keelin O'Donoghue, et al.
Talanta|April 11, 2026
Volatolomic analysis of extracellular vesicles extracted from cultured cellsRosamaria Capuano, Siong Fong Sim, Mohammad Mehedi Hasan, et al.
British Medical Bulletin|November 28, 2012
Placenta as a reservoir of stem cells: an underutilized resource?Caterina Pipino, Panicos Shangaris, Elisa Resca, et al.
Epigenetics|September 25, 2010
The effects of culture on genomic imprinting profiles in human embryonic and fetal mesenchymal stem cellsJennifer Frost, Dave Monk, Dafni Moschidou, et al.
Scientific Reports|March 12, 2020
Publisher Correction: Human mid-trimester amniotic fluid (stem) cells lack expression of the pluripotency marker OCT4AFilipa Vlahova, Kate E Hawkins, Anna Maria Ranzoni, et al.
Scientific Reports|June 1, 2019
Human mid-trimester amniotic fluid (stem) cells lack expression of the pluripotency marker OCT4AFilipa Vlahova, Kate E Hawkins, Anna Maria Ranzoni, et al.
Stem Cells and Development|October 12, 2012
Human mid-trimester amniotic fluid stem cells cultured under embryonic stem cell conditions with valproic acid acquire pluripotent characteristicsDafni Moschidou, Sayandip Mukherjee, Michael P Blundell, et al.
Stem Cells Translational Medicine|December 1, 2012
Upregulating CXCR4 in human fetal mesenchymal stem cells enhances engraftment and bone mechanics in a mouse model of osteogenesis imperfectaGemma N Jones, Dafni Moschidou, Kenneth Lay, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Frontiers in Pharmacology|March 19, 2015
Corrigendum: In utero therapy for congenital disorders using amniotic fluid stem cellsDurrgah L Ramachandra, Sheng-Wen Steven Shaw, Panicos Shangaris, et al.
Frontiers in Pharmacology|January 8, 2015
In utero therapy for congenital disorders using amniotic fluid stem cellsDurrgah L Ramachandra, Steven S W Shaw, Panicos Shangaris, et al.
Stem Cells (Dayton, Ohio)|December 23, 2006
Widespread distribution and muscle differentiation of human fetal mesenchymal stem cells after intrauterine transplantation in dystrophic mdx mouseJerry Chan, Simon N Waddington, Keelin O'Donoghue, et al.
Talanta|April 11, 2026
Volatolomic analysis of extracellular vesicles extracted from cultured cellsRosamaria Capuano, Siong Fong Sim, Mohammad Mehedi Hasan, et al.
British Medical Bulletin|November 28, 2012
Placenta as a reservoir of stem cells: an underutilized resource?Caterina Pipino, Panicos Shangaris, Elisa Resca, et al.
Epigenetics|September 25, 2010
The effects of culture on genomic imprinting profiles in human embryonic and fetal mesenchymal stem cellsJennifer Frost, Dave Monk, Dafni Moschidou, et al.
Scientific Reports|March 12, 2020
Publisher Correction: Human mid-trimester amniotic fluid (stem) cells lack expression of the pluripotency marker OCT4AFilipa Vlahova, Kate E Hawkins, Anna Maria Ranzoni, et al.
Scientific Reports|June 1, 2019
Human mid-trimester amniotic fluid (stem) cells lack expression of the pluripotency marker OCT4AFilipa Vlahova, Kate E Hawkins, Anna Maria Ranzoni, et al.
Stem Cells and Development|October 12, 2012
Human mid-trimester amniotic fluid stem cells cultured under embryonic stem cell conditions with valproic acid acquire pluripotent characteristicsDafni Moschidou, Sayandip Mukherjee, Michael P Blundell, et al.
Stem Cells Translational Medicine|December 1, 2012
Upregulating CXCR4 in human fetal mesenchymal stem cells enhances engraftment and bone mechanics in a mouse model of osteogenesis imperfectaGemma N Jones, Dafni Moschidou, Kenneth Lay, et al.
Pageof 5